Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
2004 1
2007 2
2011 1
2012 1
2013 2
2015 1
2017 3
2018 3
2019 4
2020 5
2021 2
2022 7
2023 8
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Cancer in sub-Saharan Africa: a Lancet Oncology Commission.
Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson BO, Anorlu R, Avery S, Barango P, Bih N, Booth CM, Brawley OW, Dangou JM, Denny L, Dent J, Elmore SNC, Elzawawy A, Gashumba D, Geel J, Graef K, Gupta S, Gueye SM, Hammad N, Hessissen L, Ilbawi AM, Kambugu J, Kozlakidis Z, Manga S, Maree L, Mohammed SI, Msadabwe S, Mutebi M, Nakaganda A, Ndlovu N, Ndoh K, Ndumbalo J, Ngoma M, Ngoma T, Ntizimira C, Rebbeck TR, Renner L, Romanoff A, Rubagumya F, Sayed S, Sud S, Simonds H, Sullivan R, Swanson W, Vanderpuye V, Wiafe B, Kerr D. Ngwa W, et al. Among authors: simonds h. Lancet Oncol. 2022 Jun;23(6):e251-e312. doi: 10.1016/S1470-2045(21)00720-8. Epub 2022 May 9. Lancet Oncol. 2022. PMID: 35550267 Free PMC article. Review.
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Automated Radiation Treatment Planning for Cervical Cancer.
Rhee DJ, Jhingran A, Kisling K, Cardenas C, Simonds H, Court L. Rhee DJ, et al. Among authors: simonds h. Semin Radiat Oncol. 2020 Oct;30(4):340-347. doi: 10.1016/j.semradonc.2020.05.006. Semin Radiat Oncol. 2020. PMID: 32828389 Free PMC article. Review.
Addressing the Global Expertise Gap in Radiation Oncology: The Radiation Planning Assistant.
Court L, Aggarwal A, Burger H, Cardenas C, Chung C, Douglas R, du Toit M, Jaffray D, Jhingran A, Mejia M, Mumme R, Muya S, Naidoo K, Ndumbalo J, Nealon K, Netherton T, Nguyen C, Olanrewaju N, Parkes J, Shaw W, Trauernicht C, Xu M, Yang J, Zhang L, Simonds H, Beadle BM. Court L, et al. Among authors: simonds h. JCO Glob Oncol. 2023 Jul;9:e2200431. doi: 10.1200/GO.22.00431. JCO Glob Oncol. 2023. PMID: 37471671 Free PMC article. Review.
An update on the management of breast cancer in Africa.
Vanderpuye V, Grover S, Hammad N, PoojaPrabhakar, Simonds H, Olopade F, Stefan DC. Vanderpuye V, et al. Among authors: simonds h. Infect Agent Cancer. 2017 Feb 14;12:13. doi: 10.1186/s13027-017-0124-y. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28228841 Free PMC article. Review.
Breast cancer survival in women living with HIV.
Simonds HM, Jacobson JS. Simonds HM, et al. Lancet HIV. 2022 Mar;9(3):e141-e142. doi: 10.1016/S2352-3018(22)00010-8. Lancet HIV. 2022. PMID: 35245505 No abstract available.
Automated treatment planning of postmastectomy radiotherapy.
Kisling K, Zhang L, Shaitelman SF, Anderson D, Thebe T, Yang J, Balter PA, Howell RM, Jhingran A, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM, Court L. Kisling K, et al. Among authors: simonds h. Med Phys. 2019 Sep;46(9):3767-3775. doi: 10.1002/mp.13586. Epub 2019 Jul 9. Med Phys. 2019. PMID: 31077593 Free PMC article.
The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries.
Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W Jr, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U. Grover S, et al. Among authors: simonds h. Brachytherapy. 2023 Nov-Dec;22(6):716-727. doi: 10.1016/j.brachy.2023.07.003. Epub 2023 Sep 12. Brachytherapy. 2023. PMID: 37704540
43 results